NO940810D0 - Behandling av virusinfeksjoner - Google Patents
Behandling av virusinfeksjonerInfo
- Publication number
- NO940810D0 NO940810D0 NO940810A NO940810A NO940810D0 NO 940810 D0 NO940810 D0 NO 940810D0 NO 940810 A NO940810 A NO 940810A NO 940810 A NO940810 A NO 940810A NO 940810 D0 NO940810 D0 NO 940810D0
- Authority
- NO
- Norway
- Prior art keywords
- treatment
- viral infections
- infections
- viral
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C11/00—Aliphatic unsaturated hydrocarbons
- C07C11/21—Alkatrienes; Alkatetraenes; Other alkapolyenes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2121/00—Preparations for use in therapy
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Virology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Dermatology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB939304746A GB9304746D0 (en) | 1993-03-09 | 1993-03-09 | Treatment of viral infections |
Publications (2)
Publication Number | Publication Date |
---|---|
NO940810D0 true NO940810D0 (no) | 1994-03-08 |
NO940810L NO940810L (no) | 1994-09-12 |
Family
ID=10731687
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO940810A NO940810L (no) | 1993-03-09 | 1994-03-08 | Behandling av virusinfeksjoner |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP0615752A1 (no) |
JP (1) | JPH072663A (no) |
KR (1) | KR940021056A (no) |
CN (1) | CN1100931A (no) |
AU (1) | AU5758594A (no) |
CA (1) | CA2117214A1 (no) |
GB (1) | GB9304746D0 (no) |
NO (1) | NO940810L (no) |
NZ (1) | NZ260052A (no) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19681235D2 (de) * | 1996-01-05 | 1999-03-11 | Cesa Clean Energy S A | Verfahren zur Deaktivierung der HIV und anderer Viren |
US5795909A (en) | 1996-05-22 | 1998-08-18 | Neuromedica, Inc. | DHA-pharmaceutical agent conjugates of taxanes |
US6576636B2 (en) | 1996-05-22 | 2003-06-10 | Protarga, Inc. | Method of treating a liver disorder with fatty acid-antiviral agent conjugates |
EP1042341A1 (en) * | 1997-11-25 | 2000-10-11 | Protarga Inc. | Nucleoside analog compositions and uses thereof |
DE19836339B4 (de) | 1998-08-11 | 2011-12-22 | N.V. Nutricia | Kohlenhydratmischung |
US7235583B1 (en) | 1999-03-09 | 2007-06-26 | Luitpold Pharmaceuticals, Inc., | Fatty acid-anticancer conjugates and uses thereof |
AUPR030800A0 (en) | 2000-09-22 | 2000-10-12 | Pharmalink International Limited | Immunomodulatory preparation |
ES2387562T3 (es) | 2001-03-23 | 2012-09-26 | Luitpold Pharmaceuticals, Inc. | Conjugados alcohol graso-medicamento |
AU2002303164A1 (en) | 2001-03-23 | 2002-10-08 | Protarga, Inc. | Fatty amine drug conjugates |
EP1597978A1 (en) | 2004-05-17 | 2005-11-23 | Nutricia N.V. | Synergism of GOS and polyfructose |
US8252769B2 (en) | 2004-06-22 | 2012-08-28 | N. V. Nutricia | Intestinal barrier integrity |
WO2005122791A2 (en) * | 2004-06-22 | 2005-12-29 | N.V. Nutricia | Improvement of barrier integrity in hiv patients with fatty acids |
CN110339187B (zh) * | 2019-07-30 | 2021-12-14 | 中国医学科学院病原生物学研究所 | 缓解寨卡病毒感染相关的新生儿小头症的药物 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8319073D0 (en) * | 1983-07-14 | 1983-08-17 | Efamol Ltd | Fatty acid compositions |
GB8320203D0 (en) * | 1983-07-27 | 1983-09-01 | Horrobin D F | Anti-viral compositions |
ES2040847T3 (es) * | 1987-04-27 | 1996-07-16 | Efamol Holdings | Un procedimiento para preparar una composicion farmaceutica que contiene una sal de litio. |
US4997851A (en) * | 1987-12-31 | 1991-03-05 | Isaacs Charles E | Antiviral and antibacterial activity of fatty acids and monoglycerides |
HU209973B (en) * | 1988-03-09 | 1995-01-30 | Biorex Kutato Fejlesztoe Kft | Process for production of antiviral and immunstimular pharmaceutical composition |
EP0400547A1 (en) * | 1989-06-02 | 1990-12-05 | Abbott Laboratories | Parenteral nutrition product |
GB8918294D0 (en) * | 1989-08-10 | 1989-09-20 | Efamol Holdings | Pharmaceutical compositions |
GB9111900D0 (en) * | 1991-06-03 | 1991-07-24 | Efamol Holdings | Fatty acid compositions |
WO1993000084A1 (en) * | 1991-06-24 | 1993-01-07 | Adelaide Children's Hospital | Methods and compositions for treating malaria and other diseases |
GB9116054D0 (en) * | 1991-07-24 | 1991-09-11 | Efamol Holdings | Preparation of fatty acid medicaments |
EP0585057A1 (en) * | 1992-08-25 | 1994-03-02 | Scotia Holdings Plc | Lithium salts of fatty acids for the treatment of viral infections and cancer |
-
1993
- 1993-03-09 GB GB939304746A patent/GB9304746D0/en active Pending
-
1994
- 1994-03-07 AU AU57585/94A patent/AU5758594A/en not_active Abandoned
- 1994-03-08 NO NO940810A patent/NO940810L/no unknown
- 1994-03-08 CA CA002117214A patent/CA2117214A1/en not_active Abandoned
- 1994-03-08 NZ NZ260052A patent/NZ260052A/en unknown
- 1994-03-08 JP JP6037108A patent/JPH072663A/ja active Pending
- 1994-03-09 EP EP94301654A patent/EP0615752A1/en not_active Withdrawn
- 1994-03-09 KR KR1019940004569A patent/KR940021056A/ko not_active Application Discontinuation
- 1994-03-09 CN CN94102459A patent/CN1100931A/zh active Pending
Also Published As
Publication number | Publication date |
---|---|
AU5758594A (en) | 1994-09-15 |
CN1100931A (zh) | 1995-04-05 |
EP0615752A1 (en) | 1994-09-21 |
GB9304746D0 (en) | 1993-04-28 |
NZ260052A (en) | 1997-06-24 |
CA2117214A1 (en) | 1994-09-10 |
NO940810L (no) | 1994-09-12 |
JPH072663A (ja) | 1995-01-06 |
KR940021056A (ko) | 1994-10-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO991700D0 (no) | Benzimidazol-2-karbamater for behandling av virusinfeksjoner og cancer | |
NO934304L (no) | Fremgangsmaate for behandling av fluoralumosilikatglass | |
NO934547D0 (no) | Oral behandling av Helicobacter-in-feksjon | |
NO924461D0 (no) | Dipyridamol for behandling av proliferaktive sykdommer | |
NO20005839D0 (no) | Preparater for behandling av HIV og andre virale infeksjoner | |
FI954047A0 (fi) | Ihmisen interleukiini-10:n puhdistaminen | |
DE69401115D1 (de) | Reinigung von Propylenoxid | |
NO940810D0 (no) | Behandling av virusinfeksjoner | |
EP0559791A4 (en) | Treatment of topical infections | |
DE69415387D1 (de) | Reinigung von Propylenoxid | |
FI932847A0 (fi) | HIV-proteasinhibitorer som aer anvaendbara foer behandling av aids | |
DE69102980D1 (de) | Reinigung von Siliziumtetrachlorid. | |
DE69301599D1 (de) | Reinigung von Propylenoxid | |
NO955258D0 (no) | Medisinsk anvendelse av enzymer | |
LV10191A (lv) | Farmaceitiski lidzekli hepatita B virusa izraisito infekciju un slimibu arstesanai | |
NO951995L (no) | Kombinasjon av atovaquon med proguantil for behandling av protozoinfeksjoner | |
NO942756D0 (no) | Behandling av glaucoma | |
NO940190D0 (no) | Anvendelse av x-ketoglutarat | |
FI951655A (fi) | H.pylori -infektioiden hoito | |
FI935202A0 (fi) | Tenn/ceriumfoereningar foer processering av lignosulfonat | |
AU3530395A (en) | Treatment of viral infections | |
NO965591D0 (no) | Kombinasjonsbehandling av HIV-infeksjon | |
NO931399D0 (no) | Anvendelse av naturstein | |
EP0655919A4 (en) | TREATMENT OF VIRAL INFECTIONS IN MAN. | |
FI942576A0 (fi) | Behandling av plasma |